MAIA BIOTECHNOLOGY INC (MAIA) Stock Price, Quote, News and Overview
NYSEARCA:MAIA - NYSE Arca - US5526411021 - Common Stock - Currency: USD
MAIA Quote, Performance and Key Statistics
1.71
-0.08 (-4.47%)
The current stock price of MAIA is 1.71 USD. In the past month the price decreased by -14.5%. In the past year, price decreased by -54.28%.
MAIA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.84 | 323.71B | ||
| AMGN | AMGEN INC | 13.09 | 146.07B | ||
| GILD | GILEAD SCIENCES INC | 13.87 | 133.68B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 111.96B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.28 | 63.52B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 37.81B | ||
| ARGX | ARGENX SE - ADR | 100.1 | 35.88B | ||
| ONC | BEIGENE LTD-ADR | 6 | 26.10B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.72B | ||
| NTRA | NATERA INC | N/A | 20.94B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 19.20B | ||
| BIIB | BIOGEN INC | 7.95 | 18.43B |
Related stock screener links
About MAIA
Company Profile
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. The company is headquartered in Chicago, Illinois and currently employs 13 full-time employees. The company went IPO on 2022-07-28. The firm's THIO (6-thio-dG, 6-thio-2'-deoxyguanosine), is a lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The modified nucleotide 6-thio-2-deoxyguanosine (THIO) induces telomerase-dependent telomeric DNA modification, DNA damage responses, and selective cancer cell death. THIO-damaged telomeric fragments accumulate in cytosolic micronuclei and activates both innate (cGAS/STING) and adaptive (T-cell) immune responses. The sequential treatment with THIO followed by PD-(L)1 inhibitors resulted in tumor regression in advanced, in vivo cancer models by induction of cancer type-specific immune memory. THIO is being developed as a second or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors.
Company Info
MAIA BIOTECHNOLOGY INC
444 West Lake Street, Suite 1700, Suite 1700
Chicago ILLINOIS US
Employees: 13
Phone: 13124168592
MAIA BIOTECHNOLOGY INC / MAIA FAQ
What is the stock price of MAIA BIOTECHNOLOGY INC today?
The current stock price of MAIA is 1.71 USD. The price decreased by -4.47% in the last trading session.
What is the ticker symbol for MAIA BIOTECHNOLOGY INC stock?
The exchange symbol of MAIA BIOTECHNOLOGY INC is MAIA and it is listed on the NYSE Arca exchange.
On which exchange is MAIA stock listed?
MAIA stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for MAIA BIOTECHNOLOGY INC stock?
7 analysts have analysed MAIA and the average price target is 14.28 USD. This implies a price increase of 735.09% is expected in the next year compared to the current price of 1.71. Check the MAIA BIOTECHNOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MAIA BIOTECHNOLOGY INC worth?
MAIA BIOTECHNOLOGY INC (MAIA) has a market capitalization of 51.83M USD. This makes MAIA a Micro Cap stock.
How many employees does MAIA BIOTECHNOLOGY INC have?
MAIA BIOTECHNOLOGY INC (MAIA) currently has 13 employees.
What are the support and resistance levels for MAIA BIOTECHNOLOGY INC (MAIA) stock?
MAIA BIOTECHNOLOGY INC (MAIA) has a support level at 1.7 and a resistance level at 1.8. Check the full technical report for a detailed analysis of MAIA support and resistance levels.
Should I buy MAIA BIOTECHNOLOGY INC (MAIA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MAIA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MAIA, evaluating the profitability, health, valuation and growth aspects
- MAIA BIOTECHNOLOGY INC (MAIA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MAIA BIOTECHNOLOGY INC (MAIA) Sales and EPS estimates to see what analysts future expectations are.
- MAIA BIOTECHNOLOGY INC (MAIA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MAIA BIOTECHNOLOGY INC (MAIA) Insider and Institutional Ownership to learn about the owners and their transactions.
- MAIA BIOTECHNOLOGY INC (MAIA) Stock Chart to make your own analysis
- MAIA BIOTECHNOLOGY INC (MAIA) Latest news and press-releases to stay up to date.
Does MAIA BIOTECHNOLOGY INC (MAIA) stock pay dividends?
MAIA does not pay a dividend.
What is the Price/Earnings (PE) ratio of MAIA BIOTECHNOLOGY INC (MAIA)?
MAIA BIOTECHNOLOGY INC (MAIA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.09).
What is the Short Interest ratio of MAIA BIOTECHNOLOGY INC (MAIA) stock?
The outstanding short interest for MAIA BIOTECHNOLOGY INC (MAIA) is 2.56% of its float. Check the ownership tab for more information on the MAIA short interest.
MAIA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MAIA. When comparing the yearly performance of all stocks, MAIA is a bad performer in the overall market: 86.77% of all stocks are doing better.
MAIA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MAIA. While MAIA seems to be doing ok healthwise, there are quite some concerns on its profitability.
MAIA Financial Highlights
Over the last trailing twelve months MAIA reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS increased by 26.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -228.99% | ||
| ROE | -639.81% | ||
| Debt/Equity | 0 |
MAIA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to MAIA. The Buy consensus is the average rating of analysts ratings from 7 analysts.